Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Chemsuschem
|
September 25, 2019
Solvent Selection for Lignin Value Prior to Pulping
Thomas T Kwok, John R Bright, Soor R Vora, et al.
The Journal of Urology
|
March 1, 2022
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer
John R Bright, Rosina T Lis, Anson T Ku, et al.
The Prostate
|
May 6, 2024
Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis
JuanJuan Yin, Asha Daryanani, Fan Lu, et al.
Nature Communications
|
February 15, 2020
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson, Stephanie A Harmon, Nicholas T Terrigino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition
Scott Wilkinson, Anson T Ku, Rosina T Lis, et al.
European Urology
|
March 31, 2021
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
Scott Wilkinson, Huihui Ye, Fatima Karzai, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer
Chennan Li, Ravi A Madan, Min-Jung Lee, et al.
The Journal of Clinical Investigation
|
September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition
Scott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Chemsuschem
|
September 25, 2019
Solvent Selection for Lignin Value Prior to Pulping
Thomas T Kwok, John R Bright, Soor R Vora, et al.
The Journal of Urology
|
March 1, 2022
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer
John R Bright, Rosina T Lis, Anson T Ku, et al.
The Prostate
|
May 6, 2024
Reproducible preclinical models of androgen receptor driven human prostate cancer bone metastasis
JuanJuan Yin, Asha Daryanani, Fan Lu, et al.
Nature Communications
|
February 15, 2020
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson, Stephanie A Harmon, Nicholas T Terrigino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition
Scott Wilkinson, Anson T Ku, Rosina T Lis, et al.
European Urology
|
March 31, 2021
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
Scott Wilkinson, Huihui Ye, Fatima Karzai, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2026
Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer
Chennan Li, Ravi A Madan, Min-Jung Lee, et al.
The Journal of Clinical Investigation
|
September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibition
Scott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Page
of 1